Repligen | RGEN - صافي الدخل

سعر السهم
110.12
التغيير اليومي
-4.30 -3.76%
شهريا
-11.88%
سنويا
-17.46%
Q1 التوقعات
110.89




صافي الدخل تغيير تاريخ
Agilent USD 305M 129M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
Bio Techne USD 38.01M 176K 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.2B 289M 2025-12
Dentsply International USD -146M 281M 2025-12
General Electric Aerospace USD 2.54B 384M 2025-12
Henry Schein USD 101M 0 2025-12
Illumina USD 334M 184M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Waters USD 225.21M 76.29M 2025-12
West Pharmaceutical Services USD 132.1M 7.9M 2025-12